Biohaven Ltd.BHVNNYSE
Loading
Operating Expenses Over TimeContracting
Percentile Rank83
3Y CAGR+9.3%
5Y CAGR+45.3%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+9.3%/yr
Annual compound
5Y CAGR
+45.3%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
6.5x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$741.24M-16.3%
2024$885.11M+103.0%
2023$436.05M-23.2%
2022$567.93M+159.4%
2021$218.90M+91.2%
2020$114.51M-76.1%
2019$479.12M-